文献速递流行病学与生物统计真实世界研究与卫生经济

改善活动性结核病照护级联结局:结核病干预措施的全球系统综述与Meta分析

Improving cascade outcomes for active TB: A global systematic review and meta-analysis of TB interventions.
PubMed 文献 · PLoS Med · 2023-01-03

该系统综述与Meta分析检索1970年1月至2022年9月30日的英文对照研究,纳入144项研究(128项来自中低收入国家,84项为随机对照试验),评估结核病干预对活动性结核病照护级联结局的影响。与标准治疗相比,咨询与教育、激励措施、社区干预和混合干预与多个级联结局改善相关,但异质性高,选择策略时应考虑成本效果和当地情境。

要点

  • 咨询与教育与结核病检测、诊断、照护衔接、治愈、治疗完成和治疗成功均显著相关。
  • 激励措施、多部门合作和社区干预与至少三个结核病照护级联结局相关。
  • 数字干预和混合干预分别与两个级联结局的可能性增加相关。

核心结论

  • 在结核病干预中,教育与咨询、激励措施、社区干预和混合干预与多个活动性结核病照护级联结局相关。
  • 由于异质性高,选择这些策略时应考虑成本效果和当地情境。

研究设计与样本

  • 系统综述与Meta分析,检索1970年1月至2022年9月30日发表的英文对照研究,纳入144项研究,其中128项来自中低收入国家,84项为随机对照试验,25项整合结核病与HIV照护。
  • 采用随机效应模型合并数据,以比值比(OR)及95%置信区间(CI)报告结局,并报告研究数(k),使用GRADE评价证据质量,研究注册于PROSPERO(CRD42018103331)。

主要发现

  • 与标准治疗相比,咨询与教育与检测(OR=8.82,95%CI:1.71至45.43;I²=99.9%,k=7)、诊断(OR=1.44,95%CI:1.08至1.92;I²=97.6%,k=9)、照护衔接(OR=3.10,95%CI:1.97至4.86;I²=0%,k=1)、治愈(OR=2.08,95%CI:1.11至3.88;I²=76.7%,k=4)、治疗完成(OR=1.48,95%CI:1.07至2.03;I²=73.1%,k=8)和治疗成功(OR=3.24,95%CI:1.88至5.55;I²=75.9%,k=5)结局显著相关。
  • 激励措施、多部门合作和社区干预与至少三个结核病照护级联结局相关;数字干预和混合干预分别与两个级联结局的可能性增加相关。
  • 仅限随机对照试验时,这些发现仍然显著。

局限性

  • 本研究未覆盖整个照护级联,未测量检测前、治疗前和治疗后结局(如失访和结核病复发)的差距。
  • 由于异质性高,选择策略时应考虑成本效果和当地情境。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To inform policy and implementation that can enhance prevention and improve tuberculosis (TB) care cascade outcomes, this review aimed to summarize the impact of various interventions on care cascade outcomes for active TB. METHODS AND FINDINGS: In this systematic review and meta-analysis, we retrieved English articles with comparator arms (like randomized controlled trials (RCTs) and before and after intervention studies) that evaluated TB interventions published from January 1970 to September 30, 2022, from Embase, CINAHL, PubMed, and the Cochrane library. Commentaries, qualitative studies, conference abstracts, studies without standard of care comparator arms, and studies that did not report quantitative results for TB care cascade outcomes were excluded. Data from studies with similar comparator arms were pooled in a random effects model, and outcomes were reported as odds ratio (OR) with 95% confidence interval (CI) and number of studies (k). The quality of evidence was appraised using GRADE, and the study was registered on PROSPERO (CRD42018103331). Of 21,548 deduplicated studies, 144 eligible studies were included. Of 144 studies, 128 were from low/middle-income countries, 84 were RCTs, and 25 integrated TB and HIV care. Counselling and education was significantly associated with testing (OR = 8.82, 95% CI:1.71 to 45.43; I2 = 99.9%, k = 7), diagnosis (OR = 1.44, 95% CI:1.08 to 1.92; I2 = 97.6%, k = 9), linkage to care (OR = 3.10, 95% CI = 1.97 to 4.86; I2 = 0%, k = 1), cure (OR = 2.08, 95% CI:1.11 to 3.88; I2 = 76.7%, k = 4), treatment completion (OR = 1.48, 95% CI: 1.07 to 2.03; I2 = 73.1%, k = 8), and treatment success (OR = 3.24, 95% CI: 1.88 to 5.55; I2 = 75.9%, k = 5) outcomes compared to standard-of-care. Incentives, multisector collaborations, and community-based interventions were associated with at least three TB care cascade outcomes; digital interventions and mixed interventions were associated with an increased likelihood of two cascade outcomes each. These findings remained salient when studies were limited to RCTs only. Also, our study does not cover the entire care cascade as we did not measure gaps in pre-testing, pretreatment, and post-treatment outcomes (like loss to follow-up and TB recurrence). CONCLUSIONS: Among TB interventions, education and counseling, incentives, community-based interventions, and mixed interventions were associated with multiple active TB care cascade outcomes. However, cost-effectiveness and local-setting contexts should be considered when choosing such strategies due to their high heterogeneity.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Marley G, Zou X, Nie J, et al. Improving cascade outcomes for active TB: A global systematic review and meta-analysis of TB interventions. PLoS Med. 2023. PMID: 36595536. doi:10.1371/journal.pmed.1004091

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。